Cannabis cream relieved itching symptoms over the short-term in a small trial of patients on hemodialysis experiencing uremic pruritus. In the double-blind trial (Clinicaltrials.gov Identifier ...

Simonsen E, Komenda P, Lerner B, et al. Treatment uremic pruritus: A systematic review. Am J Kidney Dis 2017; published online ahead of print. From the July 31, 2017 Issue of Renal and Urology News ...

Background. Aside from kidney transplantation, no effective treatment exists for uremic pruritus. The capacity of κ-opioid stimulation to block µ-opioid-induced itching implies that the new κ ...

Around 6+ key companies are developing Uremic Pruritus therapies. The drug candidate Difelikefalin by Cara Therapeutics has been accepted and granted priority review by the US Food and Drug ...

WASHINGTON, DC — The intensity of itch experienced by patients on hemodialysis with uremic pruritus can be eased with 12 weeks of treatment with difelikefalin (Korsuva, Cara Therapeutics ...

EP547, a potent, highly selective MrgprX4 antagonist, represents a novel, targeted approach to the treatment of cholestatic and uremic pruritus November 04, 2021 08:07 AM Eastern Daylight Time.

Cannabis on the Rise - Dermatology Pros and Cons – Topical treatments are promising, but more research is needed. Meanwhile, dermatologists should be alert to potential side effects of smoked ...

A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.Many ...

Trevi Therapeutics announced statistically significant results from its Phase 2/3 trial of Nalbuphine ER for the treatment of moderate to severe uremic pruritus.Uremic pruritus is a persistent and ...

Korsuva, Cara's FDA-approved injection for pruritus, faces challenges in capturing market share for uremic pruritus treatment due to competition, high costs, and modest efficacy.

Uremic pruritus is a debilitating symptom frequently encountered in individuals with chronic kidney disease (CKD), particularly those receiving haemodialysis. This condition, characterised by ...